Literature DB >> 11899219

Treatment of persistent chylothorax after Norwood procedure with somatostatin.

Timothy W Pettitt1, Joseph Caspi, Anne Borne.   

Abstract

A newborn who had undergone Norwood procedure for hypoplastic left heart syndrome developed a voluminous chylothorax that persisted despite weeks of prolonged complete bowel rest, total parenteral nutrition, and effective chest tube drainage. Chest tube output diminished immediately following initiation of intravenous somatostatin, allowing restoration of full enteral feeds and removal of chest tubes within 6 days.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11899219     DOI： 10.1016/s0003-4975(01)03014-4

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN： 0003-4975            Impact factor:   4.330


  7 in total

1.  Octreotide in the management of postoperative chylothorax.

Authors:  L Rosti; F De Battisti; G Butera; S Cirri; M Chessa; A Delogu; M Drago; A Giamberti; G Pomè; M Carminati; A Frigiola
Journal:  Pediatr Cardiol       Date:  2005 Jul-Aug       Impact factor: 1.655

2.  Somatostatin for intractable postoperative chylothorax in a premature infant.

Authors:  S A Clarke; K Lakhoo; W Sherwood
Journal:  Pediatr Surg Int       Date:  2005-02-12       Impact factor: 1.827

3.  Successful treatment of neonatal chylothorax with octreotide.

Authors:  Seyedeh Fatemeh Khatami; Pouya Parvaresh
Journal:  Indian J Pediatr       Date:  2011-05-28       Impact factor: 1.967

Review 4.  Surgical chylothorax in neonates: management and outcomes.

Authors:  Karina Miura Costa; Amulya Kumar Saxena
Journal:  World J Pediatr       Date:  2018-03-05       Impact factor: 2.764

5.  Octreotide in the treatment of neonatal postoperative chylothorax: report of three cases and literature review.

Authors:  João Moreira-Pinto; Paula Rocha; Angélica Osório; Berta Bonet; Fátima Carvalho; Carlos Duarte; Luísa Oliveira
Journal:  Pediatr Surg Int       Date:  2010-09-07       Impact factor: 1.827

Review 6.  Somatostatin or octreotide as treatment options for chylothorax in young children: a systematic review.

Authors:  Charles C Roehr; Andreas Jung; Hans Proquitté; Oliver Blankenstein; Hannes Hammer; Kokila Lakhoo; Roland R Wauer
Journal:  Intensive Care Med       Date:  2006-03-11       Impact factor: 17.440

7.  Somatostatin for postoperative chylothorax after surgery for children with congenital heart disease.

Authors:  Kyoung Ah Lim; Sung Hye Kim; June Huh; I-Seok Kang; Heung Jae Lee; Tae-Gook Jun; Pyo Won Park
Journal:  J Korean Med Sci       Date:  2005-12       Impact factor: 2.153
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.